Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Nurse Educ Today ; 104: 104996, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34126323

ABSTRACT

BACKGROUND: The dismissal of a nursing student is distressing for the student and may be viewed as a failure of the admissions process or a lack of support by the school to ensure student success. While student dismissal is often associated with student characteristics such as academic performance prior to enrollment or during the nursing program, there was a dearth of studies that examined student dismissal from an in-depth analysis of the student's perspective. PURPOSE: The purpose of this study was to describe and explore factors contributing to academic dismissal, particularly from the student's perspective. METHOD: Using the lens of Critical Pedagogy, the investigator interviewed nine students dismissed from a baccalaureate nursing program. Students were asked to describe their experiences from the time they decided to pursue nursing school, during school, and after dismissal. RESULTS: Findings of this study suggest that intrinsic and extrinsic factors that contribute to a student's choice of pursuing nursing warrant consideration, including a student's social and cultural factors prior to admission. CONCLUSION: Results from this study may inform those faculty and the admissions team reviewing potential students for admission into a baccalaureate nursing program of essential factors to consider prior to offering admission. A holistic evaluation of the student with consideration of social and cultural factors and readiness for entrance into a pre-licensure nursing program is the goal of the admissions process.


Subject(s)
Academic Performance , Education, Nursing, Baccalaureate , Students, Nursing , Humans , Licensure, Nursing , Schools, Nursing
2.
Musculoskelet Surg ; 104(2): 125-133, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31595426

ABSTRACT

PURPOSE: The purpose of this systematic review is to evaluate the current literature and to assess the clinical outcomes following meniscal ramp lesion treatment and anterior cruciate ligament (ACL) reconstruction. A consensus of the treatment of this pattern of tears is still lacking. METHODS: A systematic review of the literature was performed with a comprehensive search on Medline through PubMed, CINAHL, Cochrane, Embase and Google Scholar databases. The PRISMA 2009 flowchart and checklist were considered to edit the review. The included studies were evaluated based on indications, management, surgical technique and clinical results. RESULTS: Seven studies (two level II and five level IV evidence) were identified that met inclusion criteria, including a total of 509 patients. The overall main follow-up was 23.6 months. Treatment failure occurred in 8.3% of patients receiving ACL repair and ramp lesion treatment. The repair of ramp lesion is the most used approach in the literature. CONCLUSION: There is a lack of literature focused on the management of ramp lesion and ACL injuries. The repair resulted in the most used approach with good clinical results and low failure rate. However, further high-quality studies evaluating the long-term outcomes of different surgical strategies are needed.


Subject(s)
Knee Injuries/surgery , Tibial Meniscus Injuries/surgery , Adolescent , Adult , Anterior Cruciate Ligament Injuries/surgery , Arthroscopy/methods , Child , Conservative Treatment , Female , Follow-Up Studies , Humans , Joint Instability/etiology , Knee Injuries/rehabilitation , Knee Injuries/therapy , Male , Menisci, Tibial/surgery , Middle Aged , Severity of Illness Index , Tibial Meniscus Injuries/rehabilitation , Tibial Meniscus Injuries/therapy , Treatment Outcome , Young Adult
3.
Musculoskelet Surg ; 103(2): 107-113, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30270400

ABSTRACT

Patellar instability is the pathologic condition where the patella is prone to recurrent lateral dislocation. The clinical results on large series of patients and long-term outcome of Goldthwait techniques have not been described in the literature. The aim of this systematic review is: (1) to analyze and summarize the available literature focused on Goldthwait procedure in the treatment of recurrent patellar dislocation and (2) to evaluate the clinical and functional outcomes of patients treated with this surgical procedure. A systematic review of the literature was performed to investigate the results of Goldthwait procedure according to the PRISMA 2009 guidelines. A total of 7 articles published were systematically reviewed. A total of 197 knees (182 patients: 86 males and 96 females) have been treated with Goldthwait procedure. The mean reported follow-up was 6.8 years. The mean age at surgery was 18 years old. The Goldthwait procedure was associated with open lateral retinacular release in 127 (64.5%) knees to arthroscopic lateral retinacular release in 20 (10.1%) knees, and with retinacular plasty and a vastus medialis advancement in 33 (16.7%) knees. Only in 17 (8.6%) knees the Goldthwait procedure was performed as an isolated procedure. Poor standardization of methodological assessment has been observed. Despite the limitations of the available literature, the Goldthwait technique provides satisfying results for the treatment of patellar instability even in pediatric population. More high-quality studies are necessary to evaluate the long-term complications and the real incidence of long-term PF osteoarthritis.


Subject(s)
Joint Instability/surgery , Patellar Dislocation/surgery , Plastic Surgery Procedures/methods , Humans , Osteoarthritis, Knee/etiology , Postoperative Care , Postoperative Complications/etiology , Recurrence , Treatment Outcome
4.
Dis Esophagus ; 23(6): 506-11, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20113324

ABSTRACT

Patients with longstanding achalasia have an increased risk of developing esophageal cancer. Surveillance is hampered by chronic stasis. We investigated whether aberrant expressions of tumor suppressor gene p53 and proliferation marker ki67 are early predictors for progression to malignancy. In 399 achalasia patients, 4% died of esophageal cancer despite surveillance. We performed a cohort study, using surveillance biopsies from 18 patients (11 carcinoma, one high-grade dysplasia [HGD], and six low-grade dysplasia [LGD]) and 10 controls (achalasia patients without cancer or dysplasia development). One hundred sixty-four biopsies were re-evaluated and studied for p53 and ki67 expression using immunohistochemistry. Eighty-two percent of patients with cancer/HGD showed p53 overexpression in surveillance biopsies at a mean of 6 (1-11) years prior to cancer development. In 67% of patients with LGD and only in 10% of the controls p53 overexpression was present. The proportion of samples with p53 overexpression increased with increasing grades of dysplasia. We found no difference for ki67 overexpression. p53 overexpression may identify achalasia patients at increased risk of developing esophageal carcinoma. Further study is needed to determine if patients with p53 overexpression would benefit from intensive surveillance to detect esophageal neoplasia at a potential curable stage.


Subject(s)
Esophageal Achalasia/metabolism , Esophageal Neoplasms/metabolism , Precancerous Conditions/metabolism , Tumor Suppressor Protein p53/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers/metabolism , Cohort Studies , Disease Progression , Esophageal Achalasia/pathology , Esophageal Neoplasms/pathology , Gene Expression , Humans , Immunohistochemistry , Ki-67 Antigen/metabolism , Longitudinal Studies , Middle Aged , Precancerous Conditions/pathology , Risk Factors , Young Adult
5.
Q J Nucl Med Mol Imaging ; 51(4): 324-33, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17923824

ABSTRACT

AIM: Peptide receptor radionuclide therapy using the somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate is a convincing treatment modality for metastasized neuroendocrine tumors. Therapeutic doses are administered in 4 cycles with 6-10 week intervals. A high somatostatin receptor density on tumor cells is a prerequisite at every administration to enable effective therapy. In this study, the density of the somatostatin receptor subtype 2 (sst2) was investigated in the rat CA20948 pancreatic tumor model after low dose [(177)Lu-DOTA(0), Tyr(3)]octreotate administration resulting in approximately 20 Gy tumor radiation absorbed dose, whereas 60 Gy is needed to induce complete tumor regression in these and the majority of tumors. METHODS: Sixteen days after inoculation of the CA20948 tumor, male Lewis rats were injected with 185 MBq [(177)Lu-DOTA(0),Tyr(3)]octreotate to initiate a decline in tumor size. Approximately 40 days after injection, tumors re-grew progressively after initial response. Quantification of sst2 expression was performed using in vitro autoradiography on frozen sections of three groups: control (not-treated) tumors, tumors in regression and tumors in re-growth. Histology and proliferation were determined using HE- and anti-Ki-67-staining. RESULTS: The sst2 expression on CA20948 tumor cells decreased significantly after therapy to 5% of control level. However, tumors escaping from therapy showed an up-regulated sst2 level of 2-5 times higher sst2 density compared to control tumors. CONCLUSION: After a suboptimal therapeutic dose of [(177)Lu-DOTA(0),Tyr(3)]octreotate, escape of tumors is likely to occur. Since these cells show an up-regulated sst2 receptor density, a next therapeutic administration of radiolabelled sst2 analogue can be expected to be highly effective.


Subject(s)
Octreotide/analogs & derivatives , Organometallic Compounds/pharmacokinetics , Organometallic Compounds/therapeutic use , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/radiotherapy , Receptors, Somatostatin/metabolism , Animals , Cell Line, Tumor , Gene Expression Regulation, Neoplastic/radiation effects , Male , Octreotide/pharmacokinetics , Octreotide/therapeutic use , Radiopharmaceuticals/pharmacokinetics , Radiotherapy Dosage , Rats , Rats, Inbred Lew , Treatment Outcome , Up-Regulation
6.
Biochem Biophys Res Commun ; 269(3): 767-74, 2000 Mar 24.
Article in English | MEDLINE | ID: mdl-10720490

ABSTRACT

Cisplatin is a potent DNA-damaging agent that has demonstrated anticancer activities against several tumors. However, manifestation of cellular resistance is a major obstacle in anticancer therapy that severely limits the curative potential of cisplatin. Therefore, understanding the molecular basis of cisplatin resistance could significantly improve the clinical efficacy of this anticancer agent. Here, we employed Saccharomyces cerevisiae as a model organism to study cisplatin resistance mechanisms and describe a one-step cisplatin selection to identify and characterize novel cisplatin resistance genes. Screening a multicopy yeast genomic library enabled us to isolate several yeast clones for which we could confirm that the cisplatin resistance phenotype was linked to the introduced fragment. In a first attempt, a number of open reading frames could be identified. Among these genes, PDE2 and ZDS2 were repeatedly identified as genes whose overexpression confers cellular resistance to cisplatin. PDE2, encoding cAMP-phosphodiesterase 2, is of particular interest because the overexpression of this yeast gene is known to induce cisplatin resistance in mammalian cells as well, providing proof of the principle of our experimental approach. In addition, the identification of PDE2 shows that our yeast screening system can directly be informative for drug resistance in mammalian cells.


Subject(s)
Cisplatin/pharmacology , Drug Resistance, Microbial/genetics , Genome, Fungal , Saccharomyces cerevisiae/genetics , Chromosome Mapping , Chromosomes, Fungal , Cisplatin/pharmacokinetics , Genes, Fungal , Genomic Library , Mutagenesis , Open Reading Frames , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/radiation effects , Transformation, Genetic , Ultraviolet Rays
7.
Free Radic Biol Med ; 28(1): 28-38, 2000 Jan 01.
Article in English | MEDLINE | ID: mdl-10656288

ABSTRACT

Several cellular signal transduction cascades are affected by oxidative stress. In this study, the effect of hydrogen peroxide (H2O2) on the endocytosis of the epidermal growth factor (EGF) receptor was investigated. Exposure of HER14 cells to H2O2 resulted in a concentration-dependent inhibition of EGF receptor internalization. Binding studies demonstrated that this H2O2-induced inhibition in internalization was not due to altered binding of EGF to its receptor. Addition of H2O2 at different time points during internalization showed that EGF receptor internalization was rapidly reduced, suggesting that one of the first steps in the internalization process is inhibited. In addition, H2O2 inhibited the internalization of a different receptor, the chicken hepatic lectin receptor, in a concentration-dependent manner as well. Treatment of cells with another inducer of oxidative stress, cumene hydroperoxide, also resulted in a decreased internalization. Finally, we showed that H2O2 inhibited EGF-induced mono-ubiquitination of the EGF receptor pathway substrate clone 15, a process that normally occurs during EGF receptor endocytosis. These results clearly show that oxidative stress interferes with EGF signaling.


Subject(s)
Endocytosis/drug effects , ErbB Receptors/drug effects , Fibroblasts/drug effects , Hydrogen Peroxide/pharmacology , 3T3 Cells/drug effects , 3T3 Cells/metabolism , Animals , Cells, Cultured , Chickens , DNA, Complementary/genetics , Epidermal Growth Factor/metabolism , ErbB Receptors/genetics , ErbB Receptors/metabolism , Fibroblasts/metabolism , Humans , Ligands , Mice , Microscopy, Confocal , Oxidative Stress , Protein Processing, Post-Translational/drug effects , Receptors, Mitogen/drug effects , Receptors, Mitogen/metabolism , Recombinant Proteins/metabolism , Ubiquitins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...